Pioglitazone Completed Phase N/A Trials for Diabetic Nephropathies / Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00364988Pioglitazone and Losartan Provides Additional Renoprotection
NCT00232583Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
NCT00179400Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone
NCT00308373Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus